Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Nov 1;159(11):1262-1270.
doi: 10.1001/jamasurg.2024.3083.

Counseling Intervention and Cardiovascular Events in People With Peripheral Artery Disease: A Post Hoc Analysis of the BIP Randomized Clinical Trial

Collaborators, Affiliations
Randomized Controlled Trial

Counseling Intervention and Cardiovascular Events in People With Peripheral Artery Disease: A Post Hoc Analysis of the BIP Randomized Clinical Trial

Jonathan Golledge et al. JAMA Surg. .

Abstract

Importance: It is unclear whether counseling to promote walking reduces the risk of major adverse cardiovascular events (MACE) in people with peripheral artery disease (PAD).

Objective: To test whether a counseling intervention designed to increase walking reduced the risk of MACE in patients with PAD.

Design, setting, and participants: The BIP trial was a randomized clinical trial, with recruitment performed between January 2015 and July 2018 and follow-up concluded in August 2023. Participants with walking impairment due to PAD from vascular departments in the Australian cities of Brisbane, Sydney, and Townsville were randomly allocated 1:1 to the intervention or control group. Data were originally analyzed in March 2024.

Intervention: Four brief counseling sessions aimed to help patients with the challenges of increasing physical activity.

Main outcomes and measures: The primary outcome was the between-group difference in risk of MACE, which included myocardial infarction (MI), stroke, and cardiovascular death. The relationship between Intermittent Claudication Questionnaire (ICQ) scores, PAD Quality of Life (PADQOL) scores, and MACE was examined with Cox proportional hazard regression analyses.

Results: A total of 200 participants were included, with 102 allocated to the counseling intervention (51.0%) and 98 to the control group (49.0%).Participants were followed up for a mean (SD) duration of 3.5 (2.6) years. Median (IQR) participant age was 70 (63-76) years, and 56 of 200 participants (28.0%) were female. A total of 31 individuals had a MACE (composed of 19 MIs, 4 strokes, and 8 cardiovascular deaths). Participants allocated to the intervention were significantly less likely to have a MACE than participants in the control group (10 of 102 participants [9.8%] vs 21 of 98 [21.4%]; hazard ratio [HR], 0.43; 95% CI, 0.20-0.91; P = .03). Greater disease-specific quality of life (QOL) scores at 4 months (ICQ: HR per 1-percentage point increase, 0.97; 95% CI, 0.95-0.99; P < .001; PADQOL factor 3 [symptoms and limitations in physical functioning]: HR per 1-unit increase, 0.91; 95% CI, 0.84-0.98; P = .01) and at 12 months (ICQ: HR per 1-percentage point increase, 0.97; 95% CI, 0.95-0.99; P = .003; PADQOL factor 3: HR per 1-unit increase, 0.91; 95% CI, 0.84-0.98; P = .02) were associated with a lower risk of MACE. In analyses adjusted for ICQ or PADQOL factor 3 scores at either 4 or 12 months, allocation to the counseling intervention was no longer significantly associated with a lower risk of MACE.

Conclusions and relevance: This post hoc exploratory analysis of the BIP randomized clinical trial suggested that the brief counseling intervention designed to increase walking may reduce the risk of MACE, possibly due to improvement in QOL.

Trial registration: anzctr.org.au Identifier: ACTRN12614000592640.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Golledge reported grants from the National Health and Medical Research Council, the Queensland government, the Heart Foundation, the Medical Research Futures Fund, and Townsville Hospital and Health Services during the conduct of the study. Dr Leicht reported grants from the National Health and Medical Research Council during the conduct of the study. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Flowchart of Included Participants
The numbers of patients who were assessed for eligibility, randomized, attended intervention or control sessions, and completed follow-up assessments are shown. PAD indicates peripheral artery disease. aFour intervention participants completed some but not all outcome assessments when assessed at 4, 12, and 24 months, as they declined or were unable to do some of the outcome tests due to illness, adverse events, or personal reasons. bThree control participants completed some but not all outcome assessments when assessed at 4, 12, and 24 months, as they declined or were unable to do some of the outcome tests due to illness, adverse events, or personal reasons. cSeven intervention participants completed some but not all outcome assessments when assessed at 4, 12, and 24 months, as they declined or were unable to do some of the outcome tests due to illness, adverse events, or personal reasons. dTwo control participants completed some but not all outcome assessments when assessed at 4, 12, and 24 months, as they declined or were unable to do some of the outcome tests due to illness, adverse events, or personal reasons. eFive intervention participants completed some but not all outcome assessments when assessed at 4, 12, and 24 months, as they declined or were unable to do some of the outcome tests due to illness, adverse events, or personal reasons. fFive control participants completed some but not all outcome assessments when assessed at 4, 12, and 24 months, as they declined or were unable to do some of the outcome tests due to illness, adverse events, or personal reasons.
Figure 2.
Figure 2.. Effect of the Counseling Intervention on Cardiovascular Events and Relationship With Quality of Life
A, Comparison of the proportions of participants allocated to the brief counseling intervention or control group who had a major adverse cardiovascular event (MACE). The incidence of MACE was significantly lower in participants allocated to the brief counseling intervention compared with the control group (P = .02 by log-rank test). MACEs included myocardial infarction, stroke, and cardiovascular death. B, Comparison of Peripheral Artery Disease Quality of Life factor 3 (symptoms and limitations in physical functioning) scores at entry and at 4, 12, and 24 months in participants who either had a MACE or did not have a MACE. Midlines represent median values, boxes show IQR, and whiskers denote the minimum and maximum observed values.

Comment on

References

    1. Nastasi DR, Moxon JV, Norman R, et al. The cost-effectiveness of intensive low-density lipoprotein cholesterol lowering in people with peripheral artery disease. J Vasc Surg. 2021;73(4):1396-1403.e3. doi: 10.1016/j.jvs.2020.08.129 - DOI - PubMed
    1. Agnelli G, Belch JJF, Baumgartner I, Giovas P, Hoffmann U. Morbidity and mortality associated with atherosclerotic peripheral artery disease: a systematic review. Atherosclerosis. 2020;293:94-100. doi: 10.1016/j.atherosclerosis.2019.09.012 - DOI - PubMed
    1. Golledge J. Update on the pathophysiology and medical treatment of peripheral artery disease. Nat Rev Cardiol. 2022;19(7):456-474. doi: 10.1038/s41569-021-00663-9 - DOI - PubMed
    1. Golledge J, Yip L, Venn A, et al. ; BIP Investigators . Effect of brief counseling by allied health professionals on step count of people with peripheral artery disease: a randomized clinical trial. JAMA Cardiol. 2023;8(4):394-399. doi: 10.1001/jamacardio.2022.5437 - DOI - PMC - PubMed
    1. Bonaca MP, Nault P, Giugliano RP, et al. Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (further cardiovascular outcomes research with PCSK9 inhibition in subjects with elevated risk). Circulation. 2018;137(4):338-350. doi: 10.1161/CIRCULATIONAHA.117.032235 - DOI - PubMed